Testing Trauma-Focused Therapy to Reduce PTSD Symptoms in First Responders and Frontline Healthcare Workers
Delivered Through Employee Assistance Programs
Led by University of Michigan · Updated on 2026-07-01
410
Participants Needed
14
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate a brief PTSD treatment called Prolonged Exposure for Primary Care PE-PC among First Responders and Healthcare workers. The study compares this approach to standard care provided by Employee Assistance Programs EAPs to see if it reduces PTSD symptoms and improves functioning. The trial is sponsored by the University of Michigan and focuses on those with significant PTSD symptoms.
Participants receive either the PE-PC treatment, which consists of 4 to 6 weekly 30-minute sessions delivered in person or by telehealth, or the usual EAP Treatment as Usual TAU which typically includes up to six solution-focused therapy sessions and referrals for specialized PTSD care. Both treatments involve homework and surveys, with progress reviewed at the end of the PE-PC sessions. The TAU groups care is monitored throughout the study, including outside treatments and medication use.
Throughout the study, participants complete various surveys and homework assignments to track changes in PTSD symptoms, burnout, job performance, depressive symptoms, and patient satisfaction over six months. The main outcome measured is the change in PTSD symptom severity from baseline to six months. The study uses a randomized design and collects detailed monitoring data on treatment adherence and outcomes during this period.
CONDITIONS
Brief Title
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
Research Team
J
James Garlick
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
PE‑PC (condensed Prolonged Exposure)
EAP Treatment as Usual
Field‑recommended trauma‑focused therapy
What it is
A brief, condensed version of Prolonged Exposure therapy adapted for primary care settings, delivered in 4 to 6 weekly 30‑minute sessions via telehealth or in person
Standard EAP‑based care including up to six solution‑focused therapy sessions and referrals to community PTSD providers, delivered via telehealth or in person
Full Prolonged Exposure (PE) or Cognitive Processing Therapy (CPT) as guideline‑recommended trauma‑focused psychotherapies for PTSD
Role in trial
Investigational arm testing a condensed PE protocol in an EAP context
Active comparator arm representing usual EAP practice
Represents typical trauma‑focused treatment outside the trial setting
Primary use
Delivered as a short‑format, accessible PTSD treatment within EAP settings
Provides typical EAP‑based mental health support and referrals for PTSD
Widely recommended full‑length trauma‑focused psychotherapy for treating PTSD
How it is given or performed
Delivered in 4 to 6 weekly 30‑minute sessions using a condensed PE manual, via telehealth or in‑person
Delivered over approximately 4 to 6 weeks, typically involving solution‑focused therapy sessions plus referrals
Typically administered over 8 to 15 sessions following full PE or CPT protocols
Evidence status
Efficacy under investigation in this trial; no published results yet
Effectiveness reflects real‑world EAP use but lacks controlled efficacy data
High‑quality evidence from meta‑analysis supports strong symptom improvement with PE or CPT
Important risks
Potential for symptom distress during exposure; safety profile under evaluation
Variable risk depending on modality; specific safety data not provided
Trauma‑focused therapies can evoke distress during exposure; safety evidence from clinical use
Important limitations
Brief format may reduce depth of processing compared to standard PE protocols
TAU content and delivery vary by EAP site and may lack trauma‑focus
Lengthier protocols may limit accessibility and require more clinician resources
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Are employees at an organization served by a participating Employee Assistance Program (EAP)
Have a Post-Traumatic Stress Disorder Checklist for DSM-5 (PCL-5) score of 33 or higher
Have had stable psychotropic medication use for at least 4 weeks
Enrolled in the randomized clinical trial and were either treatment responders or non-responders for the qualitative portion
You will not qualify if you...
Severe cognitive impairment making adherence to the study unlikely
High risk of suicide as defined by the study's suicide risk screening
Need for detoxification
Active psychosis or unmanaged bipolar disorder as measured by specific assessments
Currently engaged in trauma-focused behavioral treatments such as Prolonged Exposure or Cognitive Processing Therapy
Do not speak English
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - 4 to 6 weeks
Participants receive either the Prolonged Exposure for Primary Care (PE-PC) therapy or the standard Employee Assistance Program Treatment as Usual (TAU). Treatments are delivered in person or by telehealth based on participant preference, with 4 to 6 weekly sessions lasting about 30 minutes each.
Weekly sessions
Follow-up
Duration - 6 months
Participants complete surveys and assessments to measure changes in PTSD symptoms, burnout, job performance, depressive symptoms, and satisfaction over six months after treatment begins.
Periodic assessments
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Partner-Assisted Versus Standard Prolonged Exposure Therapy for PTSD in Post-911 Veterans A Randomized Controlled Effectiveness Trial
Pilot Study of Video-Based Trauma-Focused Cognitive Behavioral Therapy for Adults with PTSD and Complex PTSD in Community and Hospital Mental Health Services
Testing Augmented Reality-Enhanced Exposure Therapy Compared to Traditional Therapy for PTSD in Military Personnel
Study of Ketamine and Perampanel Effects on Brain Receptors for Treating Resistant Depression
Studying How Amygdala Stimulation Can Improve Memory in Adults with Epilepsy
Using Brain Electrodes for Memory Enhancement and Seizure Monitoring
Evaluation of TSND-201 Capsules Versus Placebo for Treating PTSD in Adults
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial Assessing Safety and Efficacy
Evaluation of TSND-201 Capsules Versus Placebo for Treating Post Traumatic Stress Disorder in Adults
Study of Anger, Social Cognition, and PTSD in Former French Military Personnel Using Questionnaires and Interviews
Study of a Brief Psychological Treatment for Post-Traumatic Stress Disorder in People with Severe Mental Illness in Botswana
Digital Intervention to Support Health and Safety for Foreign-Born Immigrant Women With Lifetime Violence Exposure and PTSD or Depression
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Addressing PTSD symptoms in first responders and healthcare workers through trauma-focused treatment in Employee Assistance Programs: Protocol for a randomized controlled trial.
Rebecca K Sripada, James Garlick, Naomi Hemphill...